China SXT Pharmaceuticals, Inc. (SXTC) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

China SXT Pharmaceuticals, Inc. (SXTC) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.3M, listed on NASDAQ, employing roughly 75 people, carrying a beta of 1.96 to the broader market. China SXT Pharmaceuticals, Inc. Led by Feng Zhou, public since 2019-01-04.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for SXTC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →